Surescripts terminated its relationship with ReMy Health, making it much harder for Amazon's PillPack to access patient medication data, according to CNBC.

China has added 12 drugs, mostly chemotherapy agents, to a list of products exempt from retaliatory tariffs, according to EndPoints News.

The National Institutes of Health has launched a probe into management and workplace issues at the pharmacy that serves its research hospital in Bethesda, Md., according to the Washington Post. 

Pharmaceutical stocks dipped Sept. 10 after information about House Speaker Nancy Pelosi's drug-pricing plan surfaced, according to CNBC.

Pharmacies in New Jersey soon may be prohibited from selling tobacco products, according to NJ.com.

OxyContin maker Purdue Pharma has reached a tentative deal with 23 states and more than 2,000 cities and counties that sued the company over its role in the opioid crisis, according to The Wall Street Journal, which cited people familiar…

The union representing Hartford, Conn.-based UConn Health's pharmacists and technicians requested an injunction to stop the state Department of Correction from switching pharmaceutical providers until the change is reviewed by a judge, according to the Connecticut Post.

Generic and biosimilar drugs are becoming more expensive and less accessible to patients because of their formulary placement, according to Drug Topics.

Below are 12 legal actions involving members of the drug supply chain, including pharmaceutical manufacturers, pharmacy benefit managers, pharmacies, pharmacists, distributors and the FDA, reported by Becker's Hospital Review in the last two months:

The American Hospital Association has called UnitedHealth's recent report on specialty drug spending in hospitals and independent practices "flawed," arguing that the authors fail to account for critical differences between care settings and fail to consider that drugmakers are the…